7599 ANAGRAM DR, EDEN PRAIRIE, MN
Annual Report to Security Holders
Other Events
Reports Fiscal Q1 2026 Financial Results; Expects Product Revenue of At Least $10.5 Million in Fiscal Year 2026
I̖͔̖͔͋ǻɦۯ ŷ͔ɦͧɦ̅ǻʱ̖̅ TɦɊɦ˾ɂɦ͔ۯ
NeuroOne Fiscal Q4 2025: 907% Product Revenue Increase to $2.7M, 55.8% Gross Margin, & 163% Total Revenue Growth to $9.1M
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Announces Preliminary Unaudited Product Revenue Growth of 163% to Record $9.1 Million, Invitation to Join Virtual Investor Webinar Tomorrow at 8:30am EST
Q1
Amended Annual Report
FY 2025
Q3
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
PRER14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Initial Statement of Beneficial Ownership
Specialized Disclosure Report